Our mission
Advancing innovation to improve lives
Therapeutic areas
Find out more
Products
Find out moreAbout us
Learn how we've been delivering on our mission for patients for 90 years.
Media
ESTEVE REPORTS SIGNIFICANT GROWTH IN 2022 AND CONTINUES TO ADVANCE TOWARDS ITS VISION OF BECOMING AN INTERNATIONAL SPECIALTY PHARMA COMPANY
In 2022, the company has grown 15% in net revenues and has expanded its presence in Portugal and Italy.
To enable further growth and international expansion, ESTE...
17/05/2023
Read more
ESTEVE AND MEDTRONIC ARE COLLABORATING TO ADDRESS CANCER PAIN PATIENTS’ NEEDS
ESTEVE and MEDTRONIC have started an initiative to improve the pathway of patients with refractory cancer pain across Europe. Although most cancer sufferers respond well to co...
23/11/2022
Read more
ESTEVE REINFORCES ITS COMMITMENT TO SUSTAINABILITY IN ALL THREE DIMENSIONS: SOCIAL, ENVIRONMENTAL AND ECONOMIC
2021 has been a key year for the consolidation of its new business model: to become an international, proprietary and specialized pharmaceutical company.
Some of ...
26/05/2022
Read moreOur global presence
Get our latest news and media resources
Go